Skip to content
by Legal Desire
8 October 2026

Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes

Advising firms

Deal team

19 lawyers named
LawyerFirmSeniorityPracticeOffice
Shayne Kennedy Lead Latham & Watkins LLP Partner corporate Orange County/Bay Area
Richard Kim Latham & Watkins LLP Partner corporate Bay Area
Gregory Van Buiten Latham & Watkins LLP Associate corporate Not stated
Chantele Mansour Latham & Watkins LLP Associate corporate Not stated
Tony Noh Latham & Watkins LLP Associate corporate Not stated
Rob Rios Latham & Watkins LLP Not stated corporate Not stated
Greg Rodgers Latham & Watkins LLP Partner convertible notes Los Angeles/New York
Andrew Blumenthal Latham & Watkins LLP Partner convertible notes New York
Andrew Bentz Latham & Watkins LLP Associate convertible notes Not stated
Helen Zhang Latham & Watkins LLP Associate convertible notes Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Patrick Chew Latham & Watkins LLP Associate intellectual property Not stated
Nathan Beaton Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity Bay Area
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Jake Meninga Latham & Watkins LLP Associate tax Not stated
Derek Gumm Latham & Watkins LLP Associate tax Not stated
Francis Shih Latham & Watkins LLP Not stated tax Not stated

16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 500m (US$500 million)
What the figure measures
Issue size
Client
Latham & Watkins LLPUnderwriters
Counterparties
Vaxcyte, Inc. (Issuer)